COVID-19 nasal vaccine candidate effective at preventing disease transmissionDiseases, Conditions, Syndromes News

  • Post author:
  • Post published:September 15, 2021
  • Post category:Uncategorized

Breathe in, breathe out. That’s how easy it is for SARS-CoV-2, the virus that causes COVID-19, to enter your nose. And though remarkable progress has been made in developing intramuscular vaccines against SARS-CoV- 2, such as the readily available Pfizer, Moderna and Johnson & Johnson vaccines, nothing yet—like a nasal vaccine—has been approved to provide mucosal immunity in the nose, the first barrier against the virus before it travels down to the lungs.